JP2017501741A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501741A5
JP2017501741A5 JP2016550923A JP2016550923A JP2017501741A5 JP 2017501741 A5 JP2017501741 A5 JP 2017501741A5 JP 2016550923 A JP2016550923 A JP 2016550923A JP 2016550923 A JP2016550923 A JP 2016550923A JP 2017501741 A5 JP2017501741 A5 JP 2017501741A5
Authority
JP
Japan
Prior art keywords
chinese
patent document
document
issn
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501741A (ja
JP6890419B2 (ja
Filing date
Publication date
Priority claimed from CN201310551630.3A external-priority patent/CN104630083B/zh
Priority claimed from CN201310731833.0A external-priority patent/CN104178437B/zh
Application filed filed Critical
Priority claimed from PCT/CN2014/089882 external-priority patent/WO2015067141A1/zh
Publication of JP2017501741A publication Critical patent/JP2017501741A/ja
Publication of JP2017501741A5 publication Critical patent/JP2017501741A5/ja
Application granted granted Critical
Publication of JP6890419B2 publication Critical patent/JP6890419B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550923A 2013-11-08 2014-10-30 ラクトバチルス・クリスパタスおよびその応用 Active JP6890419B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN201310551661 2013-11-08
CN201310551661.9 2013-11-08
CN201310551630.3A CN104630083B (zh) 2013-11-08 2013-11-08 一种卷曲乳杆菌及其在妇女保健产品中的应用
CN201310551630.3 2013-11-08
CN201310731833.0A CN104178437B (zh) 2013-11-08 2013-12-26 一种卷曲乳杆菌及其在妇科疾病中的应用
CN201310731833.0 2013-12-26
PCT/CN2014/089882 WO2015067141A1 (zh) 2013-11-08 2014-10-30 一种卷曲乳杆菌及其应用

Publications (3)

Publication Number Publication Date
JP2017501741A JP2017501741A (ja) 2017-01-19
JP2017501741A5 true JP2017501741A5 (enExample) 2017-10-26
JP6890419B2 JP6890419B2 (ja) 2021-06-18

Family

ID=53040891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550923A Active JP6890419B2 (ja) 2013-11-08 2014-10-30 ラクトバチルス・クリスパタスおよびその応用

Country Status (9)

Country Link
US (1) US9937214B2 (enExample)
EP (1) EP3040413B1 (enExample)
JP (1) JP6890419B2 (enExample)
KR (1) KR101808972B1 (enExample)
ES (1) ES2670536T3 (enExample)
MY (1) MY172685A (enExample)
SG (1) SG11201603346VA (enExample)
TW (1) TWI652343B (enExample)
WO (1) WO2015067141A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11260086B2 (en) 2016-07-11 2022-03-01 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
CN109874329B (zh) * 2016-08-12 2023-08-29 深圳华大生命科学研究院 一种产丁酸栖粪杆菌及其培养方法和应用
EP3648778B1 (en) * 2017-07-07 2026-05-13 Osel, Inc. High potency stable formulations of vaginal lactobacillus
US11278581B2 (en) * 2017-07-07 2022-03-22 Osel, Inc. Use of vaginal Lactobacilli for improving the success rate of in vitro fertilization
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
EA202090750A1 (ru) * 2017-10-06 2020-11-11 Гедеа Биотек Аб Производные глюконовой кислоты для применения в лечении и/или предупреждении инфекций, вызываемых микроорганизмами
CA3101173A1 (en) 2018-05-23 2019-11-28 Ko Biolabs, Inc. Lactobacillus crispatus kbl693 strain and use thereof
GB201816425D0 (en) * 2018-10-09 2018-11-28 Tervisetehnoloogiate Arenduskeskus As Probiotics
CN109394796A (zh) * 2018-12-06 2019-03-01 青岛东海药业有限公司 卷曲乳杆菌制剂及其应用
CN112458007A (zh) * 2020-11-10 2021-03-09 深圳华大生命科学研究院 用于预防和/或治疗生殖道菌群紊乱相关疾病的卷曲乳杆菌
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
CN112708578A (zh) * 2020-12-31 2021-04-27 四川厌氧生物科技有限责任公司 一种卷曲乳杆菌及其应用
AU2021417032A1 (en) * 2021-01-05 2023-07-27 L'ORéAL S.A. Strains, compositions and methods of use
CN112899182B (zh) * 2021-01-08 2023-03-24 安徽省肿瘤医院 一种能够预防和/或治疗子宫颈鳞癌的卷曲乳杆菌
CN113512509B (zh) * 2021-05-07 2022-02-22 南方医科大学珠江医院 卷曲乳杆菌及其用途
KR102618322B1 (ko) * 2021-10-08 2023-12-27 순천향대학교 산학협력단 신규한 락토 바실러스 균주, 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN114214256B (zh) * 2022-01-12 2022-06-28 哈尔滨美华生物技术股份有限公司 一株用于防治泌尿生殖感染的格氏乳杆菌及其应用
CN114657093B (zh) * 2022-03-07 2023-07-07 北京市农林科学院 一株鸽源卷曲乳杆菌bl4014及其应用
CN116814474B (zh) * 2022-05-19 2025-07-04 广东君薇生物科技有限公司 一株卷曲乳杆菌及其应用
CN115404185A (zh) * 2022-08-31 2022-11-29 江苏新申奥生物科技有限公司 一种拮抗白色念珠菌的卷曲乳杆菌lcp051及其应用
CN116024129B (zh) * 2022-11-29 2024-09-24 光明乳业股份有限公司 一株能够与幽门螺杆菌共聚集的卷曲乳杆菌及其应用
CN116694498B (zh) * 2023-01-31 2026-02-24 江南大学 一种缓解多种阴道炎的阴道益生菌组合物
CN116286484B (zh) * 2023-02-08 2025-01-24 善恩康生物科技(苏州)有限公司 卷曲乳杆菌及其用途
KR20260006643A (ko) * 2023-06-20 2026-01-13 토요 슈가 리파이닝 컴퍼니 리미티드 세균의 증식 억제제, 그것을 포함하는 화장품, 의약 부외품 및 의약 조성물, 그리고 세균의 증식 억제 방법
CN116769676B (zh) * 2023-08-09 2023-12-05 杭州微致生物科技有限公司 一种卷曲乳杆菌及其应用
CN120330074A (zh) * 2024-01-17 2025-07-18 杭州远大生物制药有限公司 卷曲乳杆菌及其用途
WO2025207473A1 (en) * 2024-03-26 2025-10-02 Medstar Health, Inc. Methods and compositions for diagnosing and selectively treating or preventing urinary tract infection and urobiome dysbiosis
CN118256405B (zh) * 2024-05-31 2024-08-13 哈尔滨医科大学 卷曲乳杆菌fy121及其胞外囊泡在防治hpv感染及宫颈癌的应用
CN121160511A (zh) * 2024-06-17 2025-12-19 上海赛增医疗科技有限公司 新型乳杆菌菌株及其组合物和应用
CN119506125A (zh) * 2024-10-24 2025-02-25 北京科拓恒通生物技术股份有限公司 一种可促进女性生殖道健康和延缓生殖道免疫衰老的卷曲乳杆菌
CN119326803B (zh) * 2024-12-19 2025-06-27 江西益百润生物科技有限公司 一种后生元组合物的制备方法及其产品和应用
CN120648589A (zh) * 2025-05-23 2025-09-16 乾生(宁波)科技有限公司 一种改善细菌性阴道炎的益生菌及其组合物和应用
CN120775750A (zh) * 2025-09-09 2025-10-14 成都大学 一种卷曲乳杆菌及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US8329447B2 (en) 2008-12-12 2012-12-11 Osel, Inc. Strain of Lactobacillus crispatus
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
CN104178437B (zh) * 2013-11-08 2016-08-24 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇科疾病中的应用
CN104630083B (zh) * 2013-11-08 2018-07-06 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇女保健产品中的应用

Similar Documents

Publication Publication Date Title
Torres-Maravilla et al. Role of gut microbiota and probiotics in colorectal cancer: onset and progression
Liu et al. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis
Nader-Macías et al. Profiles and technological requirements of urogenital probiotics
CL2017003191A1 (es) Composiciones que comprenden cepas bacterianas
NZ777234A (en) Compositions comprising bacterial strains
MX2010003574A (es) Anticuerpos il-23.
MY156286A (en) Human il-23 antigen binding proteins
MX2015000338A (es) Novedosa cepa de lactobacillus crispatus.
MY187060A (en) Bifidobacteria as probiotic foundation species of gut microbiota
PH12019500571A1 (en) Anti-pd-1 antibodies
EP4417261A3 (en) Bacteriotherapy
IT201600091033A1 (it) Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
RU2013148473A (ru) Бактериальные штаммы, способные метаболизировать оксалаты
UA113399C2 (xx) Штам непатогенної грамнегативної бактерії та його застосування в дерматології
EA201291440A1 (ru) Пробиотические штаммы для применения при повышении трансэпителиального сопротивления
Brzuszkiewicz et al. Legionella oakridgensis ATCC 33761 genome sequence and phenotypic characterization reveals its replication capacity in amoebae
RU2012102851A (ru) Штамм enterococcus durans вкпм в-8731, используемый для производства кисломолочных продуктов и пробиотических препаратов
BR112016005509A8 (pt) método de preparação de um extrato de sementes de urucum (anato), composição, extrato vegetal, e composição farmacêutica
BR112014002911A2 (pt) linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais
WO2015168607A3 (en) Ceacam5 peptides for crohn's disease
EA201501069A1 (ru) Синбиотическая композиция для коррекции дисбиотических нарушений микробиоценоза желудочно-кишечного тракта
Bertelle-Ibrahim et al. Non-typeable Haemophilus influenzae infective endocarditis in a renal transplant recipient: compromised host or virulent strain?
PH12017500659A1 (en) Use of neridronic acid or of its salt for the treatment of osteoarthosis
Sundin et al. Gut microbiota correlate with psychological distress and intestinal lymphocyte composition in post-infectious irritable bowel syndrome patients
Prilipko et al. Analiz raboty reabilitatsionnykh meditsinskikh uchrezhdeniy zdravookhraneniya Rossiyskoy Federatsii